Hinweis-Modus ist eingeschaltet Ausschalten

BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BYXG2H39
BTEC ISIN
Exchange Traded Funds (ETF)
Fondstyp
BlackRock
Anbieter
8,63 USD
NAV pro Aktie | 11/06/2026
19/10/2017
Startdatum
Nein
Ausschüttung von Dividenden
CEOGMS
CFI
BTEC
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
Nasdaq Biotechnology Index
Benchmark
0.35 %
Gesamtkostenquote
927,7 Mio. USD
Gesamtes Fondsvermögen | 11/06/2026
873,13 Mio. USD
Aktien-Anlageklasse Volumen | 11/06/2026
Ja
UCITS

Rendite auf 18/05/2026, London S.E. (USD)

  • YTD
    0,33 %
  • 1M
    -6,52 %
  • 3M
    -4,83 %
  • 6M
    2,56 %
  • 1J
    42,2 %
  • 3J
    39,4 %
  • 5J
    -
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (BTEC)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Struktur BTEC auf 11/06/2026

Wertpapier Wertpapier
AMGEN INC 7,54%
VERTEX PHARMACEUTICALS INC 7,41%
GILEAD SCIENCES INC 6,99%
REGENERON PHARMACEUTICALS INC 5,1%
ALNYLAM PHARMACEUTICALS INC 3,08%
REVOLUTION MEDICINES INC 2,38%
BIOGEN INC 2,36%
ARGENX SE ADR 2,05%
ILLUMINA INC 2,04%
UNITED THERAPEUTICS CORP 1,92%
ROYALTY PHARMA PLC CLASS A 1,9%
INCYTE CORP 1,72%
ROIVANT SCIENCES LTD 1,71%
INSMED INC 1,68%
MODERNA INC 1,58%
VIATRIS INC 1,51%
GUARDANT HEALTH INC 1,38%
NEUROCRINE BIOSCIENCES INC 1,31%
JAZZ PHARMACEUTICALS PLC 1,17%
EXELIXIS INC 1,12%
MEDPACE HOLDINGS INC 1,08%
ASCENDIS PHARMA 1,07%
BRIDGEBIO PHARMA INC 1,05%
AXSOME THERAPEUTICS INC 1,04%
IONIS PHARMACEUTICALS INC 0,98%
MADRIGAL PHARMACEUTICALS INC 0,88%
SANOFI ADR REPRESENTING SA 0,87%
BIOMARIN PHARMACEUTICAL INC 0,86%
ARROWHEAD PHARMACEUTICALS INC 0,84%
BIONTECH SE ADR 0,82%
SUMMIT THERAPEUTICS INC 0,81%
KRYSTAL BIOTECH INC 0,76%
NUVALENT INC CLASS A 0,73%
TEMPUS AI INC CLASS A 0,69%
CYTOKINETICS INC 0,68%
HALOZYME THERAPEUTICS INC 0,67%
BEONE MEDICINES AG 0,67%
ALKERMES 0,6%
IMMUNITYBIO INC 0,59%
PROTAGONIST THERAPEUTICS INC 0,56%
PRAXIS PRECISION MEDICINES INC 0,55%
VAXCYTE INC 0,55%
KYMERA THERAPEUTICS INC 0,55%
IMMUNOVANT INC 0,54%
SPYRE THERAPEUTICS INC 0,51%
PTC THERAPEUTICS INC 0,5%
ABIVAX AMERICAN DEPOSITARY SHARES 0,5%
RHYTHM PHARMACEUTICALS INC 0,48%
MIRUM PHARMACEUTICALS INC 0,48%
COGENT BIOSCIENCES INC 0,43%
AMNEAL PHARMACEUTICALS INC CLASS A 0,41%
LIGAND PHARMACEUTICALS INC 0,41%
CARIS LIFE SCIENCES INC 0,41%
APOGEE THERAPEUTICS INC 0,39%
CG ONCOLOGY INC 0,39%
CRISPR THERAPEUTICS AG 0,39%
INDIVIOR PHARMACEUTICALS INC 0,38%
CENTESSA PHARMACEUTICALS AMERICAN 0,38%
SCHOLAR ROCK HOLDING CORP 0,36%
TWIST BIOSCIENCE CORP 0,36%
TRAVERE THERAPEUTICS INC 0,36%
XENON PHARMACEUTICALS INC 0,35%
ERASCA INC 0,35%
TANGO THERAPEUTICS INC 0,32%
VERACYTE INC 0,3%
ACADIA PHARMACEUTICALS INC 0,29%
EDGEWISE THERAPEUTICS INC 0,29%
CRINETICS PHARMACEUTICALS INC 0,28%
USD CASH 0,28%
NEWAMSTERDAM PHARMA NV 0,28%
10X GENOMICS INC CLASS A 0,28%
STRUCTURE THERAPEUTICS ADR INC 0,27%
DENALI THERAPEUTICS INC 0,27%
ORUKA THERAPEUTICS INC 0,27%
LEGEND BIOTECH ADR REP CORP 0,25%
ARCUTIS BIOTHERAPEUTICS INC 0,25%
BEAM THERAPEUTICS INC 0,24%
DYNE THERAPEUTICS INC 0,24%
ADAPTIVE BIOTECHNOLOGIES CORP 0,23%
TARSUS PHARMACEUTICALS INC 0,22%
ALUMIS INC 0,21%
SUPERNUS PHARMACEUTICALS INC 0,21%
DISC MEDICINE INC 0,21%
RELAY THERAPEUTICS INC 0,21%
IDEAYA BIOSCIENCES INC 0,21%
DEFINIUM THERAPEUTICS INC 0,2%
ENLIVEN THERAPEUTICS INC 0,19%
VERA THERAPEUTICS INC CLASS A 0,19%
KINIKSA PHARMACEUTICALS INTERNATIO 0,19%
GRAIL INC 0,19%
ULTRAGENYX PHARMACEUTICAL INC 0,19%
BIOCRYST PHARMACEUTICALS INC 0,17%
KODIAK SCIENCES INC 0,17%
AURINIA PHARMACEUTICALS INC 0,17%
HARMONY BIOSCIENCES HLDG INC 0,17%
PHARVARIS N V NV 0,16%
ADMA BIOLOGICS INC 0,16%
NOVOCURE LTD 0,16%
VERICEL CORP 0,15%
MINERALYS THERAPEUTICS INC 0,15%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.